跳到主要內容區塊
::: 目前位置:首頁 > News & Events > News

The 8th Joint Conference of Taiwan and Japan on Medical Products Regulation in Taipei on October 15th, 2020. 【發布日期:2020-10-15】 發布單位:藥品組

The 8th Joint Conference of Taiwan and Japan on Medical Products Regulation this year is taking place on October 15th, 2020 at National Biotechnology Research Park in Taipei. Due to the impact of COVID-19 pandemic, this is the first time to hold the online conference with Japan side through Webex.

Since the “Framework of the Cooperation on the Medical Products Regulation” was signed by Taiwan-Japan Relations Association and Japan-Taiwan Exchange Association in November 2013, Taiwan Food and Drug Administration (TFDA) works with Japan’s Ministry of Health, Labour, and Welfare (MHLW) and Pharmaceuticals and Medical Devices Agency (PMDA) to host Annual Joint Conference in alternative turns for eight years. This year, the representatives from TFDA and MHLW and PMDA share the latest information regarding the pharmaceutical regulations, as well as other important topics such as regulatory challenge against COVID-19, recent regulatory challenge in medical devices and Quality Management System (QMS) utilization of MOC. Apart from the TFDA and MHLW and PMDA, around 200 participants from both Taiwan and Japan’s industries join the conference. The deliverables of this conference include reaching and enhancing the mutual understandings of the regulatory information and the collaborations between regulatory authority and industries.

 

The 8th Joint Conference of Taiwan and Japan on Medical Products Regulation in Taipei on October 15th, 2020. Qrcode
資訊內容對您是否有幫助:
驗證碼
請輸入圖形認證碼內之文字